SCHEMBL6564908

SCHEMBL6564908

CCc1c(-c2csc(CCc3ccc(CO)c(CO)c3)c2)cccc1C(F)(F)C(O)(F)C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
VDR P11473 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6564892 0.89 VDR (0.38) VDR
SCHEMBL6564984 0.85 VDR (0.39) VDR
SCHEMBL6563014 0.84 VDR (0.39) VDR
SCHEMBL6564512 0.84 VDR (0.35) VDR
SCHEMBL6564912 0.80 VDR (0.39) VDR
SCHEMBL7639727 0.80 VDR (0.40) VDR
SCHEMBL6564895 0.77 VDR (0.38) VDR
SCHEMBL6564946 0.75 VDR (0.39) VDR
SCHEMBL6565120 0.74 VDR (0.38) VDR
SCHEMBL6564505 0.74 VDR (0.38) VDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235777-B1 VITAMIN D ANALOGUES GALDERMA RES & DEV (FR) 2004-06-16 EP claimed
EP-1235777-A2 VITAMIN D ANALOGUES Galderma Research & Development, S.N.C. (FR) 2002-09-04 EP disclosed
WO-2001038303-A2 VITAMIN D ANALOGUES GALDERMA RESEARCH & DEVELOPMENT, S.N.C. (FR) 2001-05-31 WO disclosed